Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

Digital holographic microscopy measured changes in nucleoli and TDP-43 cell assemblies

Original source

Detecting material state changes in the nucleolus by label-free digital holographic microscopy.EMBO Rep · 23 April 2024 (opens in a new tab)

Compass summarised this from the study's abstract.

Study details

Studied in
Human

Related topics

Researchers used label-free digital holographic microscopy and artificial intelligence to detect and measure nucleoli in human cells. The method distinguished changes caused by light-induced protein aggregation, drug treatment and loss of ribosomal proteins. It also detected cell assemblies formed when mutant TDP-43 was overproduced.[S1]

Why this matters

This could provide a way to study TDP-43-related cell changes without staining. However, the work was performed in cells and does not show that the method diagnoses ALS or changes treatment.[S1]

Limitations and context

This was a laboratory methods study using human cells, including cells with experimentally overproduced mutant TDP-43. It did not test people with ALS, establish a clinical biomarker, or evaluate treatment outcomes. The source is a primary research article, not a clinical study.

Summarised by Compass 20 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Bibliographic data from PubMed is courtesy of the U.S. National Library of Medicine. Compass does not reproduce source abstracts and may not reflect the most current record.

Relevant to you?